- Clarius and ThinkSono introduce an AI-guided ultrasound system for rapid DVT assessment in Europe.
- The system gains Class IIb CE mark regulatory approval, streamlining the DVT detection process.
- ThinkSono Guidance empowers non-ultrasound trained healthcare professionals to conduct DVT exams with Clarius scanners.
- Clinical studies validate the system’s efficacy, with ongoing trials in esteemed US institutions.
- ThinkSono leverages Clarius SDK suite for seamless integration of AI-powered solutions.
- The partnership promises to reshape DVT diagnosis, enhancing efficiency and accessibility in healthcare.
Main AI News:
In a strategic collaboration that promises to reshape DVT (Deep Vein Thrombosis) diagnosis, Clarius Mobile Health and ThinkSono unveil their groundbreaking AI-guided ultrasound system. This innovative solution, tailored for the European market, aims to streamline the detection process of DVT, a prevalent yet potentially fatal condition.
The convergence of Clarius’s expertise in high-definition handheld ultrasound systems and ThinkSono’s pioneering AI technology heralds a new era in healthcare. ThinkSono Guidance, a sophisticated AI application seamlessly integrated with Clarius ultrasound scanners, has recently garnered the prestigious Class IIb CE mark regulatory approval, underscoring its efficacy and safety.
DVT poses a significant healthcare challenge, with its propensity to cause preventable fatalities, particularly in Europe and the United States. Traditionally, patients endure prolonged waits for test results from ultrasound-trained clinicians. However, ThinkSono Guidance disrupts this paradigm by empowering non-ultrasound trained healthcare professionals to perform DVT exams using Clarius handheld ultrasound scanners. This paradigm shift significantly accelerates the diagnostic process, potentially reducing it from several hours to a mere 15 minutes.
Fouad-Al Noor, CEO, and Co-founder of ThinkSono, expresses gratitude for Clarius’s invaluable partnership in expediting the market entry of ThinkSono Guidance. “Our collaboration with Clarius underscores our commitment to enhancing DVT diagnostics by empowering non-specialized staff to conduct bedside scans,” affirms Noor. Leveraging Clarius’s research SDK, ThinkSono Guidance delivers real-time data streams, furnishing instant insights to users during ultrasound examinations.
Building upon the success of European clinical trials that facilitated regulatory approval, ongoing studies at esteemed institutions like NYU Longone Health and Temple Health in the United States underscore the system’s robustness and efficacy. These trials not only validate the system’s clinical utility but also pave the way for broader adoption across diverse healthcare settings.
ThinkSono’s journey with Clarius dates back to 2017, marked by their pioneering use of the Clarius Cast API, a testament to Clarius’s commitment to fostering innovation in healthcare. Kris Dickie, Chief Technology Officer at Clarius, lauds ThinkSono’s groundbreaking AI tools and their alignment with Clarius’s mission to democratize ultrasound technology.
Powered by the Clarius SDK suite, third-party developers can seamlessly integrate AI-driven ultrasound solutions with Clarius’s ecosystem, spanning handheld ultrasound systems, the Clarius App, and the Clarius Cloud exam management platform. This comprehensive toolkit empowers developers to accelerate the deployment of AI-powered solutions, heralding a new era of accessible, high-precision diagnostics.
As ThinkSono prepares to introduce the complete DVT solution, including Clarius ultrasound scanners, directly to key European markets like the UK, Germany, and Greece, the partnership between Clarius and ThinkSono promises to reshape the landscape of DVT diagnosis, setting new benchmarks for efficiency, accessibility, and patient care in healthcare delivery.
Conclusion:
The collaboration between Clarius and ThinkSono marks a significant advancement in DVT diagnosis, leveraging AI technology to streamline the detection process. With regulatory approval and ongoing clinical validation, this partnership is poised to disrupt the market, offering healthcare professionals a powerful tool to enhance efficiency and improve patient care. The seamless integration of AI-powered solutions further cements this innovation, setting new standards for accessibility and precision in ultrasound diagnostics.
